CMS Hospital Star Ratings Offer Limited Measure of Surgical Quality
By Elana Gotkine HealthDay Reporter
TUESDAY, June 18, 2024 -- Although the Centers for Medicare & Medicaid Services (CMS) star ratings are associated with adverse outcomes after surgery, there is wide variation in outcomes within each star rating group, according to a study published online June 18 in JAMA Surgery.
Adrian Diaz, M.D., M.P.H., from The Ohio State University in Columbus, and colleagues examined the CMS hospital star ratings and hospital surgical quality for Medicare beneficiaries undergoing colectomy, coronary artery bypass graft, cholecystectomy, appendectomy, and incisional hernia repair. Data were included for 1,898,829 patients at 3,240 hospitals with a CMS star rating.
The researchers found that the risk- and reliability-adjusted 30-day mortality rate decreased from 6.80 to 4.93 percent in one- and five-star hospitals, respectively (adjusted odds ratio, 1.86). Across all hospitals, wide variation was seen in the rates of hospital mortality, serious complications, and readmission (variation, 1.89, 1.97, and 1.27 percent, respectively). After stratifying hospitals by their star rating, similar variation patterns were seen within star-rating groups for 30-day mortality (variation, 1.91, 1.86, 1.84, 1.76, and 1.79 percent for one-, two-, three-, four-, and five-star, respectively). For serious complications and readmissions, similar patterns were seen.
"These findings highlight the limitations of the CMS star rating system as a measure of surgical quality and should be a call for continued improvement of publicly reported hospital grade measures," the authors write
One author disclosed ties to ArborMetrix.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted June 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.